Asia Pacific Vaccines Market to Reach US$ 12,631.4 Mn at CAGR of 6.4% in 2027 | The Insight Partners

Asia Pacific Vaccines Market to 2027- Regional Analysis and Forecasts By Technology (Recombinant Vaccines, Conjugate Vaccines, Live Attenuated Vaccines, Inactivated and Subunit Vaccines, and Toxoid Vaccines); Disease Indication (DTP (Diphtheria Tetanus toxoids and Pertussis), Influenza, Hepatitis, Respiratory Syncytial Virus (RSV), and Other Diseases); Route of Administration (Oral, Injectable, and Other Routes of Administration); Patient Type (Pediatric Patients, and Adult Patients), and Country

Publication Month: Jun 2019 | Report Code: TIPRE00005749 | No. of Pages: 152 | Category: Pharmaceuticals | Status: Published

The Asia Pacific human vaccines market is expected to reach US$ 12,631.4 Mn in 2027 from US$ 7,254.5 Mn in 2018. The market is estimated to grow with a CAGR of 6.4% from 2019-2027.

 

The growth of the market is driven by the factors such as rising number of awareness programs, campaigns and conferences for vaccination in Asia Pacific and growing vaccine production in Asia Pacific are likely to grow the vaccines market in the forecast period. Whereas, the mistrust on immunization in the Asia Pacific region is likely to impact the growth of the vaccines market during the forecast period.

 

Every year thousands of children in Asia Pacific region die, and many more are hospitalized due to diseases which are preventable by vaccines. The treatment cost of these diseases is very high. According to the Gavi, the Vaccine Alliance, one in every five children in Asia Pacific region don’t have access to basic vaccines. Thus in Asia Pacific region, many awareness programs have been undertaken by the government in order to raise awareness among the population.  The Immunization Partners in Asia Pacific (IPAP) arranged the 6th Asian Vaccine Conference (ASVAC 2017), in April 2017at Singapore.

 

The countries in the Asia Pacific region are joining forces to eradicate infectious diseases like measles, diphtheria, rubella, pertussis, and others through vaccinations. There are several vaccination programs, campaigns, conferences, being held in the Asia Pacific region in order to raise awareness among the population. For instance, India, along with other WHO South East Asia Region member countries, has initiated a campaign to eradicate measles and control rubella/congenital rubella syndrome (CRS) by 2020. The campaigns by the Ministry of Health & Family Welfare aims to immunize 41 crore children in India. The first phase of the campaign was successfully completed in February 2017 in five states, namely, Tamil Nadu, Karnataka, Goa, Lakshadweep, and Puducherry. Over 3.3 crore children were vaccinated, reaching out to 97% of the targeted age group. The campaign was conducted in schools, community centers, and other health facilities.

 

Japan is expected to lead the market in the Asia Pacific region due to the presence of major market players, government grants for vaccine research, and the country has strong and growing vaccination programs across the country. The development of the preventive vaccination for various diseases is likely to drive the market for vaccination in the country. Therefore, considering the above mentioned factors, the growth of the market in the country is likely to contribute the largest share in the Asia Pacific region during the forecast period.

 

 

ASIA PACIFIC VACCINES– MARKET SEGMENTATION

By Technology

  • Recombinant vaccines
  • Conjugate Vaccines
  • Live Attenuated Vaccines
  • Inactivated Vaccines
  • Toxoid Vaccines

ASIA PACIFIC VACCINES – MARKET SEGMENTATION

By Disease Indication

  • DTP (diphtheria, tetanus, and pertussis)
  • Influenza
  • Hepatitis
  • Other Diseases

ASIA PACIFIC VACCINES – MARKET SEGMENTATION

By Rout of Administration

  • Oral
  • Injectable
  • Other

ASIA PACIFIC VACCINES – MARKET SEGMENTATION

By Patient Type

  • Adults
  • Pediatric

 

By Country

  • China
  • Japan
  • India
  • Australia
  • South Korea

 

Companies Mentioned

  • PFIZER INC
  • GlaxoSmithKline plc.
  • Merck & Co., Inc.
  • Sanofi
  • Johnson & Johnson Services, Inc
  • Panacea Biotec Limited
  • Astellas Pharma Inc.
  • NOVAVAX, INC.
  • VBI Vaccines Inc
  • Bavarian Nordic

PART 1. INTRODUCTION

1.1      Scope of the Study

1.2      The Insight Partners Research Report Guidance

PART 2. aSIA paCIFIC Vaccines Market – Key takeaways

PART 3. Asia Pacific Vaccines market – market landscape

3.1      overview

3.2      market segmentation

3.2.1      Asia Pacific Vaccines Market – By Technology

3.2.2      Asia Pacific Market – By Disease Indication

3.2.3      Asia Pacific Vaccines Market – By Route of Administration

3.2.4      Asia Pacific Vaccines Market – By Patient Type

3.2.5      Asia Pacific Vaccines Market – By Country

3.3      PEST Analysis

3.3.1      Asia Pacific– PEST Analysis

PART 4. Asia Pacific VAccines market- Key Market Dynamics

4.1      Key Market Drivers

4.1.1      Rising Number of Awareness Programs, Campaigns and Conferences for Vaccination in Asia Pacific

4.1.2      Growing Vaccine Production in Asia Pacific.

4.2      Key Market Restraints

4.2.1      Mistrust of Immunization in the Asia Pacific Region.

4.3      Key Market Opportunities

4.3.1      Increasing Incidences of Infectious and Contagious Diseases

4.4      future Trends

4.4.1      Vaccine Research in  Asia

4.5      Impact analysis

PART 5. VAccines market – Asia Pacific Analysis

5.1      Asia Pacific Vaccines market Revenue Forecasts and Analysis

5.2      Market positioning

5.3      PERFORMANCE OF KEY PLAYERS

5.3.1      GlaxoSmithKline plc

PART 6. Asia Pacific vaccines market Analysis – By TEchnology

6.1      Overview

6.2      ASIA PACIFIC vaccines MARKET, BY Type, 2018 & 2027 (%)

6.3      Asia Pacific Vaccines market Revenue And Forecasts to 2027, By Technology (US$ Mn)

6.4      Asia Pacific Recombinant Vaccines Market

6.4.1      Overview

6.4.2      Asia Pacific Recombinant Vaccines Market Revenue and Forecast to 2027 (US$ Mn)

6.5      Asia Pacific Conjugate Vaccines Market

6.5.1      Overview

6.5.2      Asia Pacific Conjugate Vaccines Market Revenue and Forecast to 2027 (US$ Mn)

6.6      Asia Pacific Live Attenuated Vaccines Market

6.6.1      Overview

6.6.2      Asia Pacific Live Attenuated Vaccines Market Revenue and Forecast to 2027 (US$ Mn)

6.7      Asia Pacific Inactivated Vaccines Market

6.7.1      Overview

6.7.2      Asia Pacific Inactivated Vaccines Market Revenue and Forecast to 2027 (US$ Mn)

6.8      Asia Pacific toxoid Vaccines Market

6.8.1      Overview

6.8.2      Asia Pacific Toxoid Vaccines Market Revenue and Forecast to 2027 (US$ Mn)

PART 7. Asia Pacific Vaccines market Analysis – By Disease Indication

7.1      Overview

7.2      ASIA PACIFIC vaccines MARKET, BY disease indication, 2018 & 2027 (%)

7.3      Asia Pacific Vaccines market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

7.4      Asia Pacific DTP (diphtheria, tetanus, and pertussis) Market

7.4.1      Overview

7.4.2      Asia Pacific DTP (Diphtheria, Tetanus, And Pertussis) Market Revenue and Forecast to 2027 (US$ Mn)

7.5      Asia Pacific Influenza Market

7.5.1      Overview

7.5.2      Asia Pacific Influenza Market Revenue and Forecast to 2027 (US$ Mn)

7.6      Asia Pacific Hepatitis Market

7.6.1      Overview

7.6.2      Asia Pacific Hepatitis Market Revenue and Forecast to 2027 (US$ Mn)

7.7      Asia Pacific Other Diseases Market

7.7.1      Overview

7.7.2      Asia Pacific Other Diseases Market Revenue and Forecast to 2027 (US$ Mn)

PART 8. Asia Pacific Vaccines market Analysis – By Route of administration

8.1      Overview

8.2      ASIA PACIFIC Vaccines MARKET, BY route of administration, 2018 & 2027 (%)

8.3      Asia Pacific Vaccines market Revenue And Forecasts to 2027, By route of administration (US$ Mn)

8.4      Asia Pacific Oral Market

8.4.1      Overview

8.4.2      Asia Pacific Oral Market Revenue and Forecast to 2027 (US$ Mn)

8.5      Asia Pacific Injectable Market

8.5.1      Overview

8.5.2      Asia Pacific Injectable Market Revenue and Forecast to 2027 (US$ Mn)

8.6      Asia Pacific Other Routes of Administration Market

8.6.1      Overview

8.6.2      Asia Pacific Other Routes of Administration Market Revenue and Forecast to 2027 (US$ Mn)

PART 9. Asia Pacific Vaccines market Analysis – By Patient type

9.1      Overview

9.2      ASIA PACIFIC Vaccines MARKET, BY patient type, 2018 & 2027 (%)

9.3      Asia Pacific Vaccines market Revenue And Forecasts to 2027, By patient type (US$ Mn)

9.4      Asia Pacific pediatric Market

9.4.1      Overview

9.4.2      Asia Pacific Pediatric Market Revenue and Forecast to 2027 (US$ Mn)

9.5      Asia Pacific adults Market

9.5.1      Overview

9.5.2      Asia Pacific Adults Market Revenue and Forecast to 2027 (US$ Mn)

PART 10. Asia Pacific Vaccines market Revenue and Forecasts to 2027

10.1.1    Overview

10.1.2    Asia Pacific Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.3    Asia Pacific Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.1.4    Asia Pacific Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

10.1.5    Asia Pacific Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)

10.1.6    Asia Pacific Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)

10.1.7    Asia Pacific Vaccines Market Revenue and Forecasts to 2027, By Country (%)

10.1.8    China Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.9    China Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.9.1  China Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.1.9.2  China Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

10.1.9.3  China Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)

10.1.9.4  China Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)

10.1.10  Japan Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.11  Japan Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.11.1 Japan Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.1.11.2 Japan Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

10.1.11.3 Japan Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)

10.1.11.4 Japan Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)

10.1.12  India Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.13  India Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.13.1 India Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.1.13.2 India Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

10.1.13.3 India Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)

10.1.13.4 India Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)

10.1.14  Australia Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.15  Australia Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.15.1 Australia Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.1.15.2 Australia Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

10.1.15.3 Australia Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)

10.1.15.4 Australia Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)

10.1.16  South Korea Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.17  South Korea Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.17.1 South Korea Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.1.17.2 South Korea Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

10.1.17.3 South Korea Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)

10.1.17.4 South Korea Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)

PART 11. Vaccines Market–Key company profiles

11.1    PFIZER INC.

11.1.1    Key Facts

11.1.2    Business Description

11.1.3    Financial Overview

11.1.4    Product Portfolio

11.1.5    SWOT Analysis

11.1.6    Key Developments

11.2    GlaxoSmithKline plc.

11.2.1    Key Facts

11.2.2    Business Description

11.2.3    Financial Overview

11.2.4    Product Portfolio

11.2.5    SWOT Analysis

11.2.6    Key Developments

11.3    Merck & Co., Inc.

11.3.1    Key Facts

11.3.2    Business Description

11.3.3    Financial Overview

11.3.4    Product Portfolio

11.3.5    SWOT Analysis

11.3.6    Key Developments

11.4    Sanofi

11.4.1    Key Facts

11.4.2    Business Description

11.4.3    Financial Information

11.4.4    Product Portfolio

11.4.5    SWOT Analysis

11.4.6    Key Developments

11.5    Johnson & Johnson Services, Inc.

11.5.1    Key Facts

11.5.2    Business Description

11.5.3    Financial Overview

11.5.4    Product Portfolio

11.5.5    SWOT Analysis

11.5.6    Key Developments

11.6    Panacea Biotec Limited

11.6.1    Key Facts

11.6.2    Business Description

11.6.3    Financial Information

11.6.4    Product Portfolio

11.6.5    SWOT Analysis

11.6.6    Key Developments

11.7    Astellas Pharma Inc.

11.7.1    Key Facts

11.7.2    Business Description

11.7.3    Financial Overview

11.7.4    Product Portfolio

11.7.5    Swot Analysis

11.7.6    Key Developments

11.8    NOVAVAX, INC.

11.8.1    Key Facts

11.8.2    Business Description

11.8.3    Financial Information

11.8.4    Product Pipeline

11.8.5    SWOT Analysis

11.8.6    Key Developments

11.9    VBI Vaccines Inc.

11.9.1    Key Facts

11.9.2    Business Description

11.9.3    Financial Information

11.9.4    Product Portfolio

11.9.5    SWOT Analysis

11.9.6    Key Developments

11.10  BAVARIAN NORDIC

11.10.1  Key Facts

11.10.2  Business Description

11.10.3  Financial Information

11.10.4  Product Pipeline

11.10.5  SWOT Analysis

11.10.6  Key Developments

PART 12. Appendix

12.1    About The Insight Partners

12.2    Glossary of Terms

12.3    Methodology

12.3.1    Coverage

12.3.2    Secondary Research

12.3.3    Primary Research

LIST OF TABLES

TABLE 1.         Asia Pacific Vaccines market Revenue And Forecasts to 2027, By Technology (US$ Mn)

TABLE 2.         Asia Pacific Vaccines market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

TABLE 3.         Asia Pacific vaccines market Revenue And Forecasts to 2027, By route of administration (US$ Mn)

TABLE 4.         Asia Pacific vaccines market Revenue And Forecasts to 2027, By patient type (US$ Mn)

TABLE 5.         Asia Pacific Vaccines market Revenue And Forecasts to 2027, By Technology (US$ Mn)

TABLE 6.         Asia Pacific Vaccines market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

TABLE 7.         Asia Pacific Vaccines market Revenue And Forecasts to 2027, By Route of Administration  (US$ Mn)

TABLE 8.         Asia Pacific Vaccines market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)

TABLE 9.         CHINA Vaccines market Revenue And Forecasts to 2027, By Technology (US$ Mn)

TABLE 10.       CHINA Vaccines market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

TABLE 11.       CHINA Vaccines market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)

TABLE 12.       CHINA Vaccines market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)

TABLE 13.       JAPAN Vaccines market Revenue And Forecasts to 2027, By Technology (US$ Mn)

TABLE 14.       JAPAN Vaccines market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

TABLE 15.       JAPAN Vaccines market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)

TABLE 16.       JAPAN Vaccines market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)

TABLE 17.       INDIA Vaccines market Revenue And Forecasts to 2027, By Technology (US$ Mn)

TABLE 18.       INDIA Vaccines market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

TABLE 19.       INDIA Vaccines market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)

TABLE 20.       INDIA Vaccines market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)

TABLE 21.       AUSTRALIA Vaccines market Revenue And Forecasts to 2027, By Technology (US$ Mn)

TABLE 22.       AUSTRALIA Vaccines market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

TABLE 23.       AUSTRALIA Vaccines market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)

TABLE 24.       AUSTRALIA Vaccines market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)

TABLE 25.       SOUTH KOREA Vaccines market Revenue And Forecasts to 2027, By Technology (US$ Mn)

TABLE 26.       SOUTH KOREA Vaccines market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

TABLE 27.       SOUTH KOREA Vaccines market Revenue And Forecasts to 2027, By Route of Administration  (US$ Mn)

TABLE 28.       SOUTH KOREA Vaccines market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)

TABLE 29.       Glossary of Terms, Vaccines market

 

 

LIST OF FIGURES

FIGURE 1.       Germany Vaccines market, Revenue (US$ Mn), By COuntry 2018 & 2027

FIGURE 2.       Asia Pacific Vaccines Market By Type, Market Share (%), 2018

FIGURE 3.       Asia Pacific vaccines Market By Disease indication, Market Share (%), 2018

FIGURE 4.       Asia Pacific Vaccines Market By route of Administration, Market Share (%), 2018

FIGURE 5.       Asia Pacific Vaccines Market By Patient Type, Market Share (%), 2018

FIGURE 6.       Vaccines market Segmentation

FIGURE 7.       Asia pacific PEST Analysis

FIGURE 8.       Vaccines market impact analysis of drivers & Restraints

FIGURE 9.       Asia Pacific Vaccines market – Revenue Forecasts and Analysis – 2018- 2027

FIGURE 10.     Asia Pacific vaccines market, By Technology, 2018 & 2027 (%)

FIGURE 11.     Asia Pacific recombinant vaccines Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 12.     Asia Pacific conjugate vaccines Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 13.     Asia Pacific live attenuated vaccines Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 14.     Asia Pacific inactivated vaccines Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 15.     Asia Pacific toxoid vaccines Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 16.     Asia Pacific vaccines market By disease indication, 2017 & 2025 (%)

FIGURE 17.     Asia Pacific DTP (diphtheria, tetanus, and pertussis) Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 18.     Asia Pacific influenza Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 19.     Asia Pacific hepatitis Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 20.     Asia Pacific Other Diseases Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 21.     Asia Pacific vaccines market By route of administration, 2018 & 2027 (%)

FIGURE 22.     Asia Pacific oral Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 23.     Asia Pacific injectable Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 24.     Asia Pacific other routes of administration Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 25.     Asia Pacific vaccines market By patient type, 2018 & 2027 (%)

FIGURE 26.     Asia Pacific pediatric Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 27.     Asia Pacific adults Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 28.     Asia Pacific Vaccines market revenue Overview, by Country (2018) (us $ mn)

FIGURE 29.     Asia Pacific Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 30.     Asia Pacific Vaccines market Revenue And Forecasts to 2027, By Country (%)

FIGURE 31.     China Vaccines market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 32.     Japan Vaccines market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 33.     India Vaccines market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 34.     Australia Vaccines market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 35.     South Korea Vaccines market Revenue and Forecasts to 2027 (US$ Mn)

The List of Companies

  1. PFIZER INC
  2. GlaxoSmithKline plc.
  3. Merck & Co., Inc.
  4. Sanofi
  5. Johnson & Johnson Services, Inc
  6. Panacea Biotec Limited
  7. Astellas Pharma Inc.
  8. NOVAVAX, INC.
  9. VBI Vaccines Inc
  10. Bavarian Nordic